MTOR and breast carcinoma: We substituted BEZ235, a dual PI3K and mTOR inhibitor bearing the ability to induce apoptosis in breast cancer cells27, for FTY720 in the aforementioned protocols to determine whether the same trend for protein expression existed (Fig. 3b, Figure S5b).